CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. BioCryst Pharmaceuticals, Inc. Transaction History

CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. portfolio value:

$22,000
portfolio value

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 1.74K shares 22K $12.6 1.74K